In addition, PRKAA2 facilitates immune escape of tumor cells by promoting CD8+ T-cell exhaustion and the formation of CD4+ Treg cells by reshaping the interaction between malignant cells and T cells and driving dynamic changes in T cells in the TME. The gene discussed is CD4; the disease is neoplasm.